RGCC Immune-Frame

Discover the Power of Your Immune System

RGCC Immune-Frame test stands as an impactful tool for evaluating and understanding the features of the immune system. Utilizing cutting-edge technologies, this test assesses specific cellular markers that are responsible for the functioning of the immune system and provides a thorough assessment of immune health. The test gauges the strength of the immune system and plays a pivotal role in assessing an individual’s suitability for immunotherapies in cancer treatments.

Test

Immune-Frame

Sample Type

Whole peripheral blood sample

Sample Size

15-25ml blood

Cancers

All Types

Turnaround Time

21 days

How it works?

Immunotherapies are cancer treatments that help the immune system fight cancer. There are various types of immunotherapies such as immune checkpoint inhibitors, which work by blocking proteins that inhibit the immune response, and T-cell transfer therapy, which involves boosting the activity of T cells to enhance their ability to target cancer cells.

With the identification of blood-borne markers, the RGCC Immune-Frame test pinpoints specific cellular indicators responsible for regulating a patient’s immune system activity. This comprehensive analysis enables clinicians to assess immune function effectively and tailor treatments accordingly for cancer patients. The test pinpoints the specific biological markers to assess the status of the immune system and monitor therapeutic response to cellular therapies.

How it is done?

RGCC Immune-Frame test employs an ELISA assay to identify cytokines produced by specific cells and utilizes flow cytometry to measure markers on blood cells within the peripheral vascular system.

By analyzing specific cell markers and cytokine production, the test aids in identifying the types of cells responsible for activating or suppressing a patient’s immune system.

Why choose RGCC Immune-Frame?

RGCC Immune-Frame test serves as a valuable tool for assessing a patient’s immune system status and providing ongoing health information.

Offering a personalized analysis of an individual’s immune status, the test plays a crucial role in determining eligibility for immunotherapy options.

Which cancers are tested?

Immune-Frame used to assess the condition of patient’s immune system and provide ongoing information about health status can help plan a patient’s treatment and determine the appropriate therapy for your cancer by providing crucial information.

The test applies to all types of cancers and is not just limited to the following.

Head & Neck Cancer

Liver Cancer

Kidney Cancer

Prostate Cancer

Pancreatic Cancer

Colon Cancer

Lung Cancer

Gastric Cancer

Colorectal Cancer

Bladder Cancer

Breast Cancer

sarcoma

1

2

3

4 Why clinicians prefer RGCC Immune-Frame than other similar tests?

Dr. John Soo

“RGCC’s Immune-Frame test provides invaluable insights into a patient’s immune status. By evaluating immune function, I can tailor therapies to enhance immune response against cancer, improving treatment outcomes and patient quality of life.”

Request a Second Opinion

Our RGCC accredited experts are here to help you with their expertise and guide you in your fight against cancer.

Useful information

The test also furnishes essential details to guide treatment planning and facilitate decision-making regarding suitable immunotherapies like Dendritic cell therapies etc. The test can be used as a pre-requisite and follow-up test for patients who are looking for advanced RGCC Cellular therapy treatments.

Start your personalized cancer journey with us!

Our cutting edge diagnostics and personalised tests makes a meaningful difference in the fight against cancer.

Frequently Asked Questions

Can tests be conducted during ongoing treatment?

Absolutely, tests can be performed while undergoing treatment to assess the effectiveness of the treatment against cancer.
What happens to my blood sample post-testing?

Your blood sample undergoes processing in cutting-edge laboratories by scientists and technicians to deliver insights into your cancer cells.
Is a blood sample sufficient?

Yes, all RGCC tests utilize blood samples. However, certain cancers, like glioblastoma and brain tumors, may require additional samples such as CSF or tissue. Otherwise, a peripheral blood sample alone is enough.
Can the origin of a tumor be determined by the tests?

Yes, tests like aCGH can pinpoint the origin of an unknown primary tumor by analyzing genetic abnormalities present in tumor cells.

What tests are effective in identifying the emergence of secondary tumors?

RGCC Metastat is an effective test for identifying secondary tumors development and its potential location. It helps detect secondary tumors through analyzing Circulating Tumor Cells (CTCs) in the bloodstream. The test provides valuable insights into disease progression and metastasis.
How do tests personalize cancer treatment?

Tests personalize treatment regimens by providing crucial information on drugs and therapies tailored to effectively target cancer cells.
What are CTCs and CSCs?

Circulating Tumor Cells (CTCs) are cancer cells that have detached from the primary tumor and circulate in the bloodstream. Cancer Stem Cells (CSCs) are a subpopulation of CTCs and both serve as biomarkers for cancer.
Do tests reveal drug response and sensitivity to immunotherapy?

Tests like ChemoSNiP and CAMBISeq provide information on the body’s response to the drugs and sensitivity to immunotherapy.

Gain personalized insights into your immune system for precise, targeted cancer treatment.

Are you seeking personalized insights into your immune system to ensure precise and targeted cancer treatment? RGCC Immune Frame provides accurate information about your immune system, empowering clinicians to deliver treatments specifically tailored to your need

Offering personalized tests from RGCC, our mission is to improve treatment outcomes, enhance survival rates, and elevate overall quality of life for those affected by cancer.

Quick links

Work hours

Office landline

040 35744618

+91 7893562434

+91 78932 11234

Tap To Calll